BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8641752)

  • 1. Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes.
    Kokai-Kun JF; McClane BA
    Infect Immun; 1996 Mar; 64(3):1020-5. PubMed ID: 8641752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.
    Wieckowski EU; Kokai-Kun JF; McClane BA
    Infect Immun; 1998 Dec; 66(12):5897-905. PubMed ID: 9826371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of Clostridium perfringens enterotoxin action at different temperatures demonstrate a correlation between complex formation and cytotoxicity.
    McClane BA; Wnek AP
    Infect Immun; 1990 Sep; 58(9):3109-15. PubMed ID: 2117579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin.
    Smedley JG; Uzal FA; McClane BA
    Infect Immun; 2007 May; 75(5):2381-90. PubMed ID: 17307943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of receptors for Clostridium perfringens type A and cholera enterotoxins in isolated rabbit intestinal brush border membranes.
    Wnek AP; McClane BA
    Microb Pathog; 1986 Feb; 1(1):89-100. PubMed ID: 2854596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes.
    Wnek AP; McClane BA
    Infect Immun; 1989 Feb; 57(2):574-81. PubMed ID: 2536357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that an approximately 50-kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically bound Clostridium perfringens enterotoxin.
    Wieckowski EU; Wnek AP; McClane BA
    J Biol Chem; 1994 Apr; 269(14):10838-48. PubMed ID: 8144671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
    Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
    Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.
    Krivan HC; Clark GF; Smith DF; Wilkins TD
    Infect Immun; 1986 Sep; 53(3):573-81. PubMed ID: 3744552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant C-terminal toxin fragment provides evidence that membrane insertion is important for Clostridium perfringens enterotoxin cytotoxicity.
    Hanna PC; McClane BA
    Mol Microbiol; 1991 Jan; 5(1):225-30. PubMed ID: 2014001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes.
    McClane BA
    Toxicology; 1994 Feb; 87(1-3):43-67. PubMed ID: 8160188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters.
    Rolfe RD
    Infect Immun; 1991 Apr; 59(4):1223-30. PubMed ID: 1900806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis.
    Kokai-Kun JF; Benton K; Wieckowski EU; McClane BA
    Infect Immun; 1999 Nov; 67(11):5634-41. PubMed ID: 10531210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region.
    Hanna PC; Mietzner TA; Schoolnik GK; McClane BA
    J Biol Chem; 1991 Jun; 266(17):11037-43. PubMed ID: 1645721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.
    Smedley JG; Saputo J; Parker JC; Fernandez-Miyakawa ME; Robertson SL; McClane BA; Uzal FA
    Infect Immun; 2008 Aug; 76(8):3793-800. PubMed ID: 18505809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin.
    Shrestha A; Mehdizadeh Gohari I; McClane BA
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848291
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a 50,000 Mr protein from rabbit brush border membranes that binds Clostridium perfringens enterotoxin.
    Wnek AP; McClane BA
    Biochem Biophys Res Commun; 1983 May; 112(3):1099-105. PubMed ID: 6303335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium perfringens type A enterotoxin damages the rabbit colon.
    Garcia JP; Li J; Shrestha A; Freedman JC; Beingesser J; McClane BA; Uzal FA
    Infect Immun; 2014 Jun; 82(6):2211-8. PubMed ID: 24643537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants.
    Robertson SL; Smedley JG; Singh U; Chakrabarti G; Van Itallie CM; Anderson JM; McClane BA
    Cell Microbiol; 2007 Nov; 9(11):2734-55. PubMed ID: 17587331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion analysis of the Clostridium perfringens enterotoxin.
    Kokai-Kun JF; McClane BA
    Infect Immun; 1997 Mar; 65(3):1014-22. PubMed ID: 9038311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.